Abstract
Objective: The interaction between carbamazepine and bromperidol was studied in 13 schizophrenic inpatients.
Methods: Before carbamazepine addition, the subjects were taking bromperidol 12–24 mg · day−1 for 1–20 weeks. Carbamazepine 400 mg · day−1 was coadministered for 4 weeks, and blood samplings were performed before carbamazepine addition and at weekly intervals after the addition. Plasma concentrations of bromperidol and its reduced metabolite were measured by high-performance liquid chromatography.
Results: Carbamazepine significantly decreased plasma concentrations of both bromperidol and reduced bromperidol for all weeks. On average, the plasma concentrations of bromperidol and reduced bromperidol at 4 weeks were 37% and 23% of the corresponding precarbamazepine values. Despite these decreases in plasma concentration, the Clinical Global Impression scores decreased slightly but significantly after carbamazepine addition.
Conclusion: The present study suggests that carbamazepine decreases plasma concentrations of bromperidol and its reduced metabolite by inducing the metabolism of these compounds. Nevertheless, adjunctive carbamazepine may be useful for schizophrenic patients treated with bromperidol.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 18 June 1996 / Accepted in revised form: 23 December 1996
Rights and permissions
About this article
Cite this article
Otani, K., Ishida, M., Yasui, N. et al. Interaction between carbamazepine and bromperidol. E J Clin Pharmacol 52, 219–222 (1997). https://doi.org/10.1007/s002280050277
Issue Date:
DOI: https://doi.org/10.1007/s002280050277